GAMT anticorps (N-Term)

N° du produit ABIN631157

L’anticorps Lapin Polyclonal anti-GAMT a été validé pour WB. Il convient pour détecter GAMT dans des échantillons de Humain.

Aperçu rapide pour GAMT anticorps (N-Term) (ABIN631157)

Antigène: GAMT (Guanidinoacetate N-Methyltransferase (GAMT))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp GAMT est non-conjugé

Application: Western Blotting (WB)

Détail du produit anti-GAMT anticorps

Épitope: N-Term

Specificité: GAMT antibody was raised against the N terminal of GAMT

Purification: Affinity purified

Immunogène: GAMT antibody was raised using the N terminal of GAMT corresponding to a region with amino acids MSAPSATPIFAPGENCSPAWGAAPAAYDAADTHLRILGKPVMERWETPYM

Information d'application

Indications d'application: WB: 0.25 µg/mL
Optimal conditions should be determined by the investigator.

Commentaires:

GAMT Blocking Peptide, (ABIN5613722), is also available for use as a blocking control in assays to test for specificity of this GAMT antibody

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Lyophilized powder. Add distilled water for a 1 mg/mL concentration of GAMT antibody in PBS

Concentration: Lot specific

Buffer: PBS

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.

Détails sur GAMT

Antigène: GAMT (Guanidinoacetate N-Methyltransferase (GAMT))

Autre désignation: GAMT

Sujet: GAMT is a methyltransferase that converts guanidoacetate to creatine, using S-adenosylmethionine as the methyl donor. Defects in its gene have been implicated in neurologic syndromes and muscular hypotonia, probably due to creatine deficiency and accumulation of guanidinoacetate in the brain of affected individuals.

Poids moléculaire: 26 kDa (MW of target protein)